BCYC
Price
$25.09
Change
-$0.89 (-3.43%)
Updated
Feb 29, 6:59 PM EST
62 days until earnings call
DYN
Price
$26.90
Change
+$1.92 (+7.69%)
Updated
Feb 29, 6:59 PM EST
61 days until earnings call
Ad is loading...

Compare predictions BCYC vs DYN

Header iconBCYC vs DYN Comparison
Open Charts BCYC vs DYNBanner chart's image
Bicycle Therapeutics
Price$25.09
Change-$0.89 (-3.43%)
Volume$87.3K
CapitalizationN/A
Dyne Therapeutics
Price$26.90
Change+$1.92 (+7.69%)
Volume$1.55M
CapitalizationN/A
View a ticker or compare two or three
BCYC vs DYN Comparison Chart

Loading...

BCYCDaily Signal changed days agoGain/Loss if shorted
 
Show more...
DYNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
BCYC vs. DYN commentary
Mar 01, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCYC is a Buy and DYN is a StrongBuy.

COMPARISON
Comparison
Mar 01, 2024
Stock price -- (BCYC: $25.10 vs. DYN: $26.87)
Brand notoriety: BCYC and DYN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCYC: 57% vs. DYN: 97%
Market capitalization -- BCYC: $950.8M vs. DYN: $2.18B
BCYC [@Biotechnology] is valued at $950.8M. DYN’s [@Biotechnology] market capitalization is $2.18B. The market cap for tickers in the [@Biotechnology] industry ranges from $541.24B to $0. The average market capitalization across the [@Biotechnology] industry is $2.59B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCYC’s FA Score shows that 0 FA rating(s) are green whileDYN’s FA Score has 0 green FA rating(s).

  • BCYC’s FA Score: 0 green, 5 red.
  • DYN’s FA Score: 0 green, 5 red.
According to our system of comparison, BCYC is a better buy in the long-term than DYN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCYC’s TA Score shows that 5 TA indicator(s) are bullish while DYN’s TA Score has 4 bullish TA indicator(s).

  • BCYC’s TA Score: 5 bullish, 4 bearish.
  • DYN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, BCYC is a better buy in the short-term than DYN.

Price Growth

BCYC (@Biotechnology) experienced а +4.67% price change this week, while DYN (@Biotechnology) price change was +19.90% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.64%. For the same industry, the average monthly price growth was +16.56%, and the average quarterly price growth was +43.85%.

Reported Earning Dates

BCYC is expected to report earnings on May 02, 2024.

DYN is expected to report earnings on May 01, 2024.

Industries' Descriptions

@Biotechnology (+5.64% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for BCYC with price predictions.
OPEN
A.I.dvisor published
a Summary for DYN with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
DYN($2.18B) has a higher market cap than BCYC($951M). DYN YTD gains are higher at: 102.030 vs. BCYC (38.827). BCYC has higher annual earnings (EBITDA): -169.4M vs. DYN (-212.94M). BCYC has more cash in the bank: 526M vs. DYN (158M). DYN has less debt than BCYC: DYN (28.2M) vs BCYC (45M). BCYC has higher revenues than DYN: BCYC (27M) vs DYN (0).
BCYCDYNBCYC / DYN
Capitalization951M2.18B44%
EBITDA-169.4M-212.94M80%
Gain YTD38.827102.03038%
P/E RatioN/AN/A-
Revenue27M0-
Total Cash526M158M333%
Total Debt45M28.2M160%
TECHNICAL ANALYSIS
Technical Analysis
BCYCDYN
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
81%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
87%
Momentum
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 3 days ago
85%
MACD
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 1 day ago
89%
Declines
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 8 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
89%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
78%
View a ticker or compare two or three
Ad is loading...
BCYCDaily Signal changed days agoGain/Loss if shorted
 
Show more...
DYNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HFDRX18.680.14
+0.76%
Hartford Schroders US MidCap Opps R3
TMIFX9.610.07
+0.73%
Transamerica Mid Cap Growth R4
LCLIX41.720.21
+0.51%
ClearBridge Large Cap Value 1
CSPAX66.130.17
+0.26%
American Funds SMALLCAP World 529A
CEIIX12.73N/A
N/A
Manning & Napier Callodine Equity Inc I

BCYC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCYC has been loosely correlated with PHIO. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if BCYC jumps, then PHIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCYC
1D Price
Change %
BCYC100%
-3.39%
PHIO - BCYC
41%
Loosely correlated
+9.74%
MLTX - BCYC
39%
Loosely correlated
-15.07%
ABUS - BCYC
37%
Loosely correlated
-2.60%
ORMP - BCYC
35%
Loosely correlated
-3.81%
SAGE - BCYC
34%
Loosely correlated
-4.72%
More

DYN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DYN has been loosely correlated with AXON. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if DYN jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DYN
1D Price
Change %
DYN100%
+7.57%
AXON - DYN
43%
Loosely correlated
-0.62%
KROS - DYN
43%
Loosely correlated
-0.84%
KYMR - DYN
42%
Loosely correlated
-1.55%
GERN - DYN
42%
Loosely correlated
+3.08%
RNA - DYN
41%
Loosely correlated
+20.05%
More